Remove Cannabinoids Remove CBD Remove Conditions
article thumbnail

Video: Cannabinoid Hyperemesis Syndrome

Project CBD

Project CBD speaks with Dr. Ethan Russo about Cannabinoid Hyperemesis Syndrome, an enigmatic medical condition.

article thumbnail

CBD, THC & CBG for Skin Conditions

Project CBD

Cannabinoid compounds show promise in treating skin diseases, both as topical applications and as systemic medication.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent

NORML

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. ” They concluded : “CBD sellers should stop promoting claims that are not backed by scientific evidence.

CBD 296
article thumbnail

"Legacy" Medical Cannabis Conditions

Project CBD

New studies on cannabinoids for glaucoma, nausea, and insomnia.

article thumbnail

CBD Enhances Glucose Metabolism via Nuclear Receptors

Project CBD

Cannabinoid receptors CB1 and CB2 are the definitive and best-known targets of endogenous and plant-derived cannabinoids, but they’re far from the only ones. This may help to explain how CBD, which has little affinity for either CB1 or CB2, can do so much. The prescription was 600 mg of pure CBD orally per day for 30 days.

CBD 294
article thumbnail

CBD, THC & CBG for Skin Conditions

Project CBD

Anyone who has paid any attention to the cannabis “wellness” industry in recent years — whether through state medical and recreational programs or the free-for-all national CBD market — will be familiar with cannabinoid-infused topicals marketed to treat minor aches and pains.

article thumbnail

CBD Science Update

Project CBD

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 222